José María Bravo-Ferrer

1.5k total citations
11 papers, 129 citations indexed

About

José María Bravo-Ferrer is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, José María Bravo-Ferrer has authored 11 papers receiving a total of 129 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Pharmacology. Recurrent topics in José María Bravo-Ferrer's work include Antibiotic Use and Resistance (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). José María Bravo-Ferrer is often cited by papers focused on Antibiotic Use and Resistance (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). José María Bravo-Ferrer collaborates with scholars based in Spain, Belgium and Uganda. José María Bravo-Ferrer's co-authors include Jesús Rodríguez‐Baño, Tomislav Kostyanev, Herman Goossens, Rafael Cantón, María García-Castillo, Sandra Reuter, Hajo Grundmann, Basil Britto Xavier, Y. Glupczynski and Christine Lammens and has published in prestigious journals such as Nature Communications, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

José María Bravo-Ferrer

11 papers receiving 128 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José María Bravo-Ferrer Spain 6 74 38 31 26 25 11 129
Carlos Mejía-Villatoro Guatemala 6 64 0.9× 69 1.8× 50 1.6× 27 1.0× 22 0.9× 10 143
Felix D. Rozenberg United States 6 81 1.1× 27 0.7× 33 1.1× 54 2.1× 18 0.7× 8 159
Zhusheng Guo China 6 91 1.2× 29 0.8× 53 1.7× 27 1.0× 21 0.8× 11 183
Brânduşa Elena Lixandru Romania 4 62 0.8× 42 1.1× 32 1.0× 25 1.0× 36 1.4× 6 137
Galina Reshedko Russia 5 72 1.0× 23 0.6× 48 1.5× 29 1.1× 20 0.8× 7 129
Nadine Yared Lebanon 4 61 0.8× 63 1.7× 67 2.2× 41 1.6× 19 0.8× 4 156
Juana Ortellado Paraguay 5 54 0.7× 35 0.9× 20 0.6× 9 0.3× 30 1.2× 14 102
Pham Thi Thanh Tam Vietnam 8 41 0.6× 32 0.8× 31 1.0× 14 0.5× 20 0.8× 15 133
Surafel Fentaw Ethiopia 7 50 0.7× 14 0.4× 33 1.1× 27 1.0× 23 0.9× 13 112
Şirin Menekşe Türkiye 7 116 1.6× 34 0.9× 45 1.5× 30 1.2× 47 1.9× 17 158

Countries citing papers authored by José María Bravo-Ferrer

Since Specialization
Citations

This map shows the geographic impact of José María Bravo-Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José María Bravo-Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José María Bravo-Ferrer more than expected).

Fields of papers citing papers by José María Bravo-Ferrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José María Bravo-Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José María Bravo-Ferrer. The network helps show where José María Bravo-Ferrer may publish in the future.

Co-authorship network of co-authors of José María Bravo-Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of José María Bravo-Ferrer. A scholar is included among the top collaborators of José María Bravo-Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José María Bravo-Ferrer. José María Bravo-Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kostyanev, Tomislav, José María Bravo-Ferrer, María García-Castillo, et al.. (2024). International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe. Nature Communications. 15(1). 5092–5092. 39 indexed citations
2.
4.
Kostyanev, Tomislav, Basil Britto Xavier, María García-Castillo, et al.. (2021). Phenotypic and molecular characterizations of carbapenem-resistant Acinetobacter baumannii isolates collected within the EURECA study. International Journal of Antimicrobial Agents. 57(6). 106345–106345. 28 indexed citations
5.
Veloz, María Fernanda Guerra, et al.. (2020). LIVER MANIFESTATIONS IN COVID-19 AND THE INFLUENCE OF PRE-EXISTING LIVER DISEASE IN THE COURSE OF THE INFECTION. Revista Española de Enfermedades Digestivas. 113(2). 103–109. 12 indexed citations
7.
Gutiérrez‐Gutiérrez, Belén, Jesús Sojo-Dorado, José María Bravo-Ferrer, et al.. (2017). EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study. BMJ Open. 7(4). e015365–e015365. 17 indexed citations
8.
Kestler, Martha, Patricia Muñóz, Mercedes Marín, et al.. (2017). Endocarditis caused by anaerobic bacteria. Anaerobe. 47. 33–38. 19 indexed citations
9.
Bravo-Ferrer, José María, et al.. (2015). FRI0208 Metabolic Syndrome in Spondyloarthritis. Prevalence and Associated Factors. Annals of the Rheumatic Diseases. 74. 499–500. 2 indexed citations
10.
Bravo-Ferrer, José María, et al.. (2011). Glucocorticoides en artritis reumatoide: ¿casi siempre o casi nunca?. Reumatología Clínica. 7(6). 407–411. 2 indexed citations
11.
Bravo-Ferrer, José María, et al.. (2011). Glucocorticoids in Rheumatoid Arthritis: Almost Always or Hardly Ever?. Reumatología Clínica (English Edition). 7(6). 407–411. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026